Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Proteobacteria |
Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Gemcitabine |
Click to Show/Hide the Detail |
Drug ID |
DR0765
Drug Info
|
Interaction Mechanism |
Human Uridine/cytidine monophosphate kinase (UMPK) and Escherichia coli co-metabolize the drug Gemcitabine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Klebsiella pneumoniae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Gemcitabine |
Click to Show/Hide the Detail |
Drug ID |
DR0765
Drug Info
|
Interaction Mechanism |
Human Uridine/cytidine monophosphate kinase (UMPK) and Klebsiella pneumoniae co-metabolize the drug Gemcitabine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Tenericutes |
Mycoplasma hyorhinis (mycoplasmas) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Gemcitabine |
Click to Show/Hide the Detail |
Drug ID |
DR0765
Drug Info
|
Interaction Mechanism |
Human Uridine/cytidine monophosphate kinase (UMPK) and Mycoplasma hyorhinis co-metabolize the drug Gemcitabine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
|
|
|
|
|
|